The recent success of therapies directly targeting the angiogenic mediator. vascular endothelial growth factor (VEGF). for the treatment of proliferative diabetic retinopathy has encouraged clinicians to extend the use of anti-VEGF therapies for the treatment of another ischemic retinal vascular disease. proliferative sickle cell retinopathy (PSR). https://parisnaturalfoodes.shop/product-category/herbatint-7r/